Miriam Lenhard

3.4k total citations · 1 hit paper
42 papers, 2.5k citations indexed

About

Miriam Lenhard is a scholar working on Reproductive Medicine, Genetics and Immunology. According to data from OpenAlex, Miriam Lenhard has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 11 papers in Genetics and 10 papers in Immunology. Recurrent topics in Miriam Lenhard's work include Ovarian cancer diagnosis and treatment (14 papers), Estrogen and related hormone effects (9 papers) and Reproductive System and Pregnancy (7 papers). Miriam Lenhard is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Estrogen and related hormone effects (9 papers) and Reproductive System and Pregnancy (7 papers). Miriam Lenhard collaborates with scholars based in Germany, Austria and Canada. Miriam Lenhard's co-authors include Thorsten R. C. Johnson, Klaus Friese, Sabine Weckbach, Maximilian F. Reiser, Bernhard Krauß, Christoph R. Becker, Doris Mayr, Martin Sedlmair, Michael Grasruck and Dominik Morhard and has published in prestigious journals such as Circulation, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Miriam Lenhard

42 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Material differentiation by dual energy CT: initial experience

2006 1.2k citations Thorsten R. C. Johnson, Bernhard Krauß et al. European Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miriam Lenhard Germany	23	1.1k	1.1k	392	325	272	42	2.5k
François Tranquart France	29	769 0.7×	1.2k 1.1×	222 0.6×	284 0.9×	220 0.8×	81	2.3k
A.M. Lutz United States	31	960 0.9×	1.4k 1.3×	115 0.3×	541 1.7×	511 1.9×	81	2.8k
Wilfred Levin Canada	29	737 0.7×	341 0.3×	486 1.2×	355 1.1×	705 2.6×	74	2.7k
Youngsun Kim South Korea	28	500 0.4×	555 0.5×	240 0.6×	121 0.4×	962 3.5×	73	3.1k
Melinda Sanders United States	24	235 0.2×	351 0.3×	357 0.9×	397 1.2×	246 0.9×	52	2.0k
Hiromitsu Onishi Japan	23	1.1k 1.0×	408 0.4×	160 0.4×	175 0.5×	294 1.1×	95	2.2k
Isamu Narabayashi Japan	23	1.1k 1.0×	261 0.2×	151 0.4×	94 0.3×	585 2.2×	132	2.2k
Dae Chul Jung South Korea	26	963 0.9×	500 0.5×	341 0.9×	228 0.7×	383 1.4×	104	2.2k
Marrije R. Buist Netherlands	28	252 0.2×	227 0.2×	825 2.1×	380 1.2×	592 2.2×	48	2.0k
Robert S. Malyapa United States	35	576 0.5×	313 0.3×	84 0.2×	402 1.2×	900 3.3×	78	3.1k

Countries citing papers authored by Miriam Lenhard

Since Specialization

Citations

This map shows the geographic impact of Miriam Lenhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Lenhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Lenhard more than expected).

Fields of papers citing papers by Miriam Lenhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Lenhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Lenhard. The network helps show where Miriam Lenhard may publish in the future.

Co-authorship network of co-authors of Miriam Lenhard

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Lenhard. A scholar is included among the top collaborators of Miriam Lenhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Lenhard. Miriam Lenhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hertlein, Linda, et al.. (2014). Malnutrition and clinical outcome in gynecologic patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 174. 137–140. 32 indexed citations

Heublein, Sabine, Thomas Vrekoussis, Christina Kühn, et al.. (2013). Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation. Journal of Reproductive Immunology. 97(1). 95–103. 25 indexed citations

Heublein, Sabine, Doris Mayr, Thomas Vrekoussis, et al.. (2013). The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients. PLoS ONE. 8(8). e71791–e71791. 38 indexed citations

Lenhard, Miriam, Sabine Heublein, Christiane Kunert‐Keil, et al.. (2013). Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer. BMC Cancer. 13(1). 616–616. 22 indexed citations

Heublein, Sabine, Thomas Vrekoussis, Doris Mayr, et al.. (2013). Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR). Journal of Ovarian Research. 6(1). 6–6. 18 indexed citations

Heublein, Sabine, Harald Hessel, Alexander Burges, et al.. (2013). KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants. BMC Cancer. 13(1). 483–483. 11 indexed citations

Johnson, Thorsten R. C., Isabelle Himsl, Karin Hellerhoff, et al.. (2012). Dual-energy CT for the evaluation of silicone breast implants. European Radiology. 23(4). 991–996. 18 indexed citations

Scholz, Christoph, Sabine Heublein, Miriam Lenhard, et al.. (2012). Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients. BMC Research Notes. 5(1). 551–551. 32 indexed citations

Ditsch, Nina, Doris Mayr, Miriam Lenhard, et al.. (2012). Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncology Letters. 4(4). 665–671. 19 indexed citations

10.

Heublein, Sabine, Miriam Lenhard, Thomas Vrekoussis, et al.. (2012). The G-Protein-Coupled Estrogen Receptor (GPER) is Expressed in Normal Human Ovaries and is Upregulated in Ovarian Endometriosis and Pelvic Inflammatory Disease Involving the Ovary. Reproductive Sciences. 19(11). 1197–1204. 36 indexed citations

11.

Heublein, Sabine, Miriam Lenhard, Ulrich Andergassen, et al.. (2012). Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients. BMC Cancer. 12(1). 600–600. 18 indexed citations

12.

Lenhard, Miriam, P Stieber, Linda Hertlein, et al.. (2011). The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. Clinical Chemistry and Laboratory Medicine (CCLM). 49(12). 2081–8. 55 indexed citations

13.

Hertlein, Linda, Miriam Lenhard, Steffen Kahlert, et al.. (2010). Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients. Archives of Gynecology and Obstetrics. 283(1). 109–113. 42 indexed citations

14.

Gainford, M. Corona, Anna V. Tinker, Jonathan Carter, et al.. (2010). Malignant Transformation Within Ovarian Dermoid Cysts: An Audit of Treatment Received and Patient Outcomes. An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) Study. International Journal of Gynecological Cancer. 20(1). 75–81. 14 indexed citations

15.

Lenhard, Miriam, Carolin Kümper, P Stieber, et al.. (2009). Long-term follow-up after ovarian borderline tumor: Relapse and survival in a large patient cohort. European Journal of Obstetrics & Gynecology and Reproductive Biology. 145(2). 189–194. 54 indexed citations

16.

Lenhard, Miriam, Dorothea Nagel, Doris Mayr, et al.. (2009). Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors. Clinical Chemistry and Laboratory Medicine (CCLM). 47(5). 537–42. 36 indexed citations

17.

Brüning, Ansgar, Martina Rahmeh, Andrea Gingelmaier, et al.. (2008). Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells. Biochemical and Biophysical Research Communications. 377(4). 1309–1314. 12 indexed citations

18.

Lenhard, Miriam, Ingo Bauerfeind, & Michael Untch. (2008). Breast cancer and pregnancy: Challenges of chemotherapy. Critical Reviews in Oncology/Hematology. 67(3). 196–203. 20 indexed citations

19.

Lenhard, Miriam, Thorsten R. C. Johnson, Isabelle Himsl, et al.. (2006). Obstetrical and gynecological writing and publishing in Europe. European Journal of Obstetrics & Gynecology and Reproductive Biology. 129(2). 119–123. 7 indexed citations

20.

Gasser, Martin, Ana Maria Waaga-Gasser, Martin Grimm, et al.. (2005). Selectin Blockade Plus Therapy with Low-Dose Sirolimus and Cyclosporin A Prevent Brain Death-Induced Renal Allograft Dysfunction. American Journal of Transplantation. 5(4). 662–670. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact